Boditech Med

Boditech Med, established in 1998, is a prominent global leader in the field of in-vitro diagnostic solutions, specializing in point-of-care testing. With a strong commitment to enhancing health and quality of life, the company has developed an extensive portfolio of 85 biomarkers. These biomarkers support diverse testing modalities, including capillary blood, venous blood, and plasma, catering to the evolving needs of healthcare professionals and patients worldwide. Boditech Med operates within the Test & Measurement Equipment and Manufacturing industries, leveraging its technological expertise to deliver innovative diagnostic tools.

As a publicly traded entity on the KOSDAQ, Boditech Med demonstrates significant operational scale and market penetration. The company's product suite is designed for rapid, accurate, and accessible diagnostics, empowering clinicians with critical information at the point of care. This focus on user-friendly and efficient testing solutions has enabled Boditech Med to serve a broad international market. Meet Boditech Med's team to understand the expertise driving their innovation and global outreach.

Boditech Med's impact extends across 120 countries, solidifying its position as a key player in global healthcare diagnostics. The company's revenue stands at $32.56M, supported by a dedicated workforce of 500 - 1,000 employees. Its strategic development of diagnostic tests, ranging from rapid tests to complex biomarker assays, underscores its dedication to advancing medical diagnostics and improving patient outcomes on a global scale. The company's headquarters are located in South Korea.